Merck (MRK) FDA approves Belzutifan/Keytruda combination treatment for kidney cancer

Newsquawk StaffPublished On the live feed at 3 more headlines followed before this page went public
Newsquawk headlinesUTC

US President Trump told Axios in a short call that he considered Araghchi's post "very positive."; The president said he still thinks a deal could be signed over the weekend or on Monday.

Goldman Sachs (GS) and Morgan Stanley (MS) to pocket USD 100mln each in SpaceX IPO fees, via WSJ

Merck (MRK) FDA approves Belzutifan/Keytruda combination treatment for kidney cancer

Pakistan PM Sharif says can confirm that a final, agreed upon text of the peace deal has been reached and Pakistan is now working closely with both sides to finalize the next steps

TradeDesk (TTD) reportedly settles dispute over ad-tech fees, according to Adage

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.

Related headlines

The whole workspace, free to try.

Try it free